Mirikizumab Eases Bowel Urgency in Crohn’s Disease

Mirikizumab shows early and sustained efficacy in reducing bowel urgency and achieving remission in patients with moderate-to-severe Crohn’s disease.
Medscape Medical News

source https://www.medscape.com/viewarticle/mirikizumab-eases-bowel-urgency-crohns-disease-2025a1000k52?src=rss

Comments

Popular posts from this blog

RA and RA-ILD Linked to Higher Lung Cancer Risk

New AAFP practice guideline sets blood pressure targets for adults with hypertension